Calumet Inc
CLMT
56.29
+0.08
+0.14%
Calumet Inc
US · CLMT
#2145 by market cap
Listed 1970
56.29
+0.08
+0.14%
Live - 5344 symbols - heartbeat 370s ago
· 2026-10-08 07:36
Pre-market
57.60
+2.33%
After-hours
56.29
0.00%
Overnight
55.39
-1.60%
- Market cap
- 4.95B
- P/E (TTM)i
- -36.55
- P/Bi
- -4.35
- EPSi
- -0.39
- Div yieldi
- 0.00%
- 52W posi
- 92%
Reader sentiment
Are you bullish or bearish on CLMT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.73, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.25% YoY
Margins
- Gross margin
- 5.94%
- Operating margin
- 1.31%
- Net margin
- -0.82%
Key ratios & quality
- Enterprise valuei
- 7.12B
- Altman Z-Scorei
- 1.73
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.50B | 3.45B | 2.27B | 3.15B | 4.69B | 4.18B | 4.19B | 4.14B |
| Gross profit | 436.70M | 451.70M | 99.10M | 142.90M | 351.70M | 451.70M | 230.80M | 245.70M |
| Selling & admin expenses | 317.90M | 312.70M | 138.90M | 203.90M | 197.30M | 187.90M | 201.20M | 171.70M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 118.10M | 122.00M | -65.10M | -81.50M | 132.60M | 270.70M | 10.10M | 54.20M |
| Pretax profit | -50.30M | -43.10M | -147.90M | -258.60M | -169.90M | 49.70M | -221.20M | -126.40M |
| Tax | 700.00K | 500.00K | 1.10M | 1.50M | 3.40M | 1.60M | 800.00K | -92.60M |
| Net profit | -55.10M | -43.60M | -149.00M | -260.10M | -173.30M | 48.10M | -222.00M | -33.80M |
| Basic EPS | -1 | -1 | -2 | -3 | -2 | 1 | -3 | 0 |
| Diluted EPS | -0.69 | -0.55 | -1.86 | -3.23 | -2.14 | 0.59 | -2.67 | -0.39 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 993.90M | 1.03B | 1.08B | 1.04B | 1.03B | 1.45B |
| Gross profit | -81.40M | -43.60M | 373.70M | -3.00M | -87.50M | 18.30M |
| Selling & admin expenses | 24.40M | 53.30M | 42.30M | 51.70M | 78.30M | 52.90M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -110.90M | -101.00M | 329.30M | -63.20M | -171.30M | -40.00M |
| Pretax profit | -161.60M | -147.70M | 272.00M | -89.10M | -337.80M | -117.10M |
| Tax | 400.00K | 200.00K | -41.40M | -51.80M | -20.80M | -21.20M |
| Net profit | -162.00M | -147.90M | 313.40M | -37.30M | -317.00M | -95.90M |
| Basic EPS | -2 | -2 | 4 | 0 | -4 | -1 |
| Diluted EPS | -1.87 | -1.70 | 3.61 | -0.43 | -3.64 | -1.09 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 670.00M | 512.10M | 534.90M | 632.60M | 819.60M | 794.70M | 766.00M | 857.80M |
| Cash & ST investments | 155.70M | 19.10M | 109.40M | 38.10M | 35.20M | 7.90M | 38.10M | 125.10M |
| Inventory | 284.10M | 292.60M | 254.90M | 326.60M | 497.70M | 439.40M | 416.30M | 385.20M |
| Total assets | 2.09B | 1.86B | 1.81B | 2.13B | 2.74B | 2.75B | 2.76B | 2.69B |
| Total current liabilities | 415.10M | 565.00M | 544.50M | 899.80M | 1.35B | 1.11B | 863.60M | 840.70M |
| Short-term debt | 3.80M | 62.40M | 44.30M | 72.50M | 90.30M | 131.30M | 94.30M | 220.40M |
| Long-term debt | 1.60B | 1.21B | 1.32B | 1.42B | 1.54B | 1.83B | 2.06B | 2.08B |
| Total liabilities | 2,021,800,000.00 | 1,836,200,000.00 | 1,936,900,000.00 | 2,513,000,000.00 | 3,028,700,000.00 | 2,996,000,000.00 | 3,224,500,000.00 | 3,176,000,000.00 |
| Total equity | 65.70M | 21.60M | -128.60M | -385.10M | -287.70M | -244.70M | -466.30M | -487.10M |
| Retained earnings | -- | -- | -- | -- | -- | -- | -1.54B | -1.57B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 917.90M | 895.80M | 880.10M | 857.80M | 927.90M | 1.02B |
| Cash & ST investments | 123.40M | 110.60M | 94.60M | 125.10M | 138.60M | 109.80M |
| Inventory | 389.40M | 370.50M | 400.10M | 385.20M | 369.50M | 421.00M |
| Total assets | 2.82B | 2.78B | 2.73B | 2.69B | 2.76B | 2.80B |
| Total current liabilities | 869.10M | 1.18B | 776.30M | 840.70M | 963.10M | 1.22B |
| Short-term debt | 23.90M | 231.80M | 155.20M | 220.40M | 32.60M | 33.50M |
| Long-term debt | 2.30B | 2.11B | 2.15B | 2.08B | 2.30B | 2.23B |
| Total liabilities | 3,440,300,000.00 | 3,540,500,000.00 | 3,183,600,000.00 | 3,176,000,000.00 | 3,547,600,000.00 | 3,689,300,000.00 |
| Total equity | -616.70M | -764.10M | -449.70M | -487.10M | -792.60M | -886.50M |
| Retained earnings | -1.70B | -1.85B | -1.54B | -1.57B | -1.89B | -1.99B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 75.20M | 191.90M | 62.80M | -44.00M | 100.60M | -14.90M | -46.40M | 108.90M |
| Depreciation & amortization | 118.10M | 110.10M | 105.10M | 107.70M | 98.30M | 146.80M | 149.00M | 148.80M |
| Free cash flow | 25.40M | 137.00M | 18.80M | -126.90M | -435.60M | -286.70M | -123.10M | 56.60M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 155.70M | 19.10M | 109.40M | 121.90M | 35.20M | 14.70M | 45.90M | 205.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -29.30M | -1.80M | 23.50M | 116.50M | -86.20M | 92.30M |
| Depreciation & amortization | 37.00M | 36.70M | -- | -- | 33.00M | 34.60M |
| Free cash flow | -46.90M | -15.40M | 15.10M | 103.80M | -99.40M | 54.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 203.40M | 190.60M | 174.60M | 205.10M | 178.60M | 149.80M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -58.19 | -97.82 | -- | -- | -- | -- | -- | -- |
| ROA %i | -2.26 | -2.16 | -7.96 | -12.95 | -6.65 | 1.71 | -8.06 | -1.24 |
| ROIC %i | 3.15 | 3.71 | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -46.33 | -63.21 | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.01 | 2.65 | -0.97 | -3.47 | 0.16 | 6.49 | 0.37 | 2.16 |
| FCF / sales %i | 0.73 | 3.97 | 0.83 | -- | -- | -- | -- | 1.37 |
| Current ratioi | 1.61 | 0.91 | 0.98 | 0.70 | 0.61 | 0.71 | 0.89 | 1.02 |
| Quick ratioi | 0.85 | 0.37 | 0.50 | 0.32 | 0.22 | 0.26 | 0.37 | 0.43 |
| Debt / assetsi | 76.86 | 70.24 | 77.89 | 74.46 | 60.84 | 72.69 | 84.88 | 91.45 |
| LT debt / equityi | 2,436.38 | 5,752.31 | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 0.68 | 0.68 | -0.17 | -0.73 | 0.04 | 1.22 | 0.07 | 0.41 |
| Revenue CAGR (3Y) %i | -3.81 | -0.21 | -15.53 | -3.45 | 10.72 | 22.61 | 9.99 | -4.07 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -16.92 | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -12.36 | -16.62 | -1.38 | -1.24 | -6.77 | -4.90 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -2.56 | -5.40 | 3.65 | 2.16 | -2.26 | -1.41 |
| FCF / sales %i | -- | -- | -- | 1.37 | 0.10 | 1.60 |
| Current ratioi | 1.06 | 0.76 | 1.13 | 1.02 | 0.96 | 0.84 |
| Quick ratioi | 0.49 | 0.35 | 0.48 | 0.43 | 0.52 | 0.43 |
| Debt / assetsi | 82.38 | 84.18 | 84.22 | 91.45 | 84.65 | 80.59 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -0.46 | -0.95 | 0.65 | 0.41 | -0.45 | -0.31 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Specialty Products and Solutions is the largest reported line at 70.69% of revenue, across 4 reported segments.
- The next-largest line, Montana/Renewables, is a distant second at 22.77% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Specialty Products and Solutions70.69%
Montana/Renewables22.77%
Performance Brands7.17%
Quote time 2026-10-08 07:36:26 · For reference only, not investment advice and not tailored to your situation.